# Maze Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/maze-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 20 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-04T04:46:02.027675+00:00 | | Last reviewed | 2026-10-04T04:46:02.027675+00:00 | ## Identity - Legal name: Maze Therapeutics, Inc. - Display name: Maze Therapeutics, Inc. ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Hervé Hoppenot: Chairman of the Board. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. - Charles Homcy: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:6. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Daniel Spiegelman: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Jason Coloma: Chief Executive Officer and Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. - Jason Coloma, Ph.D.: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:9. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Jonathan Lim: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:10. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Nancy C. Andrews: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Neil Kumar: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:12. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Richard Scheller: Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:13. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456. - Atul Dandekar: Chief Strategy and Business Officer. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. - Charles E. Phillips: General Counsel and Corporate Secretary. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:15. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2880105a7bedf661b10c485c988d1ae4abe3b742beeb4169f8a92cade14488b5. - Courtney Phillips: General Counsel and Corporate Secretary. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. - Harold S. Bernstein: President, Research and Development and Chief Medical Officer. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. - Harold S. Bernstein, M.D., Ph.D.: President, Research and Development and Chief Medical Officer. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:18. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:76a067e50604d613b769c2e7ec1dd87c822be4c0c6fe623073200a2e562e04aa. - Jason Coloma: Chief Executive Officer. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. - Jason Coloma, Ph.D.: Chief Executive Officer and Director. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:20. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ea90fb70cbab8f7fddcaaf63f545131f4b8678bfc3fee014dfbd9a289a79e080. - Misbah Tahir: Chief Financial Officer. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Maze Therapeutics, Inc.. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af28e13bd27204dfd70833f3fb1119ce0622e5c2aa8dbca475ac3b0ba2b542a1. ## Entity Status - Public listing published. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af28e13bd27204dfd70833f3fb1119ce0622e5c2aa8dbca475ac3b0ba2b542a1. ## Published Fact - US. Claim: alpha:claim:company:7cade7c1-5a29-4c8c-8f8e-8d24c55c66a1:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af28e13bd27204dfd70833f3fb1119ce0622e5c2aa8dbca475ac3b0ba2b542a1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:af28e13bd27204dfd70833f3fb1119ce0622e5c2aa8dbca475ac3b0ba2b542a1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/maze-therapeutics-inc). - alpha:projection-evidence:document:f719ebb98efde141e99999532dc8ee475a21209ce1891d9f0b5117d0e0ff3171: [SEC DEF 14A 0001140361-26-017463](https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm). - alpha:projection-evidence:document:e27ccd7d3c3c110d490ef7255c90ae7d0051a382bc78ad2b2504f40a21ad2456: [DEF 14A ef20071652_def14a.htm](https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm). - alpha:projection-evidence:document:2880105a7bedf661b10c485c988d1ae4abe3b742beeb4169f8a92cade14488b5: [MAZE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm). - alpha:projection-evidence:document:76a067e50604d613b769c2e7ec1dd87c822be4c0c6fe623073200a2e562e04aa: [MAZE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm). - alpha:projection-evidence:document:ea90fb70cbab8f7fddcaaf63f545131f4b8678bfc3fee014dfbd9a289a79e080: [MAZE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1842295/000114036126017463/ef20071652_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/maze-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/maze-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/maze-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/maze-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible.